An important role of SREBP-1 in HBV and HCV co-replication inhibition by PTEN

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

HBV HCV co-infection leads to more severe liver diseases including liver cancer than mono-infections. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN), a tumor suppressor, inhibits sterol regulatory element binding protein-1 (SREBP-1). In this study, we characterized the effect of the PTEN – SREBP-1 pathway on HBV HCV co-replication in a cellular model. We found that HBV and HCV can co-replicate in Huh-7 cells with no interference. Overexpression of PTEN inhibits, whereas PTEN knockdown enhances, HBV replication as well as HBV and HCV co-replication. Knocking down SREBP-1 decreases HBV replication in an HBx-dependent manner. SREBP-1 knockdown also decreases HCV replication. PTEN knockdown is concomitant with increased nuclear SREBP-1 levels. PTEN and SREBP-1 double knockdown results in intermediate levels of HBV and HCV replication in mono- and co-replication scenarios. Taken together, we demonstrated, for the first time, that the PTEN – SREBP-1 pathway can regulate HBV HCV co-replication.

Author supplied keywords

Cite

CITATION STYLE

APA

Wu, Q., Li, Z., & Liu, Q. (2018). An important role of SREBP-1 in HBV and HCV co-replication inhibition by PTEN. Virology, 520, 94–102. https://doi.org/10.1016/j.virol.2018.05.011

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free